Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : Lifts 2021 Guidance For COVID-19 Vaccine Sales

07/28/2021 | 08:45am EDT


ę MT Newswires 2021
All news about PFIZER, INC.
05:35pADRs End Lower; WPP, BioNTech Among Companies Actively Trading
DJ
04:41pSCHOOL DISRUPTION, 'LONG COVID,' ALL : Tam
AQ
04:37pPFIZER : OPKO Health Get FDA Extension for Review of Somatrogon Biologics License Applicat..
MT
04:20pPFIZER : Residents of Saugeen First Nation given expired COVID-19 Pfizer vaccine for weeks
AQ
02:55pWALMART : Sam's Club to Administer Pfizer COVID-19 Booster Shots
MT
02:19pMODERNA : U.S. administers 388.6 mln doses of COVID-19 vaccines - CDC
RE
01:34pEquities Fluctuate Midday as Real Estate, Tech Among Worst Performers
MT
01:33pEXPLAINER : Who's eligible for Pfizer booster shots in US?
AQ
01:27pWALGREENS BOOTS ALLIANCE : Who can get a COVID-19 vaccine booster in the United States?
RE
01:23pMIDDAY REPORT : US Stocks Fluctuate as Real Estate, Tech Among Worst Performers; Digital C..
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 115 M - -
Net income 2021 18 438 M - -
Net Debt 2021 28 980 M - -
P/E ratio 2021 13,0x
Yield 2021 3,59%
Capitalization 246 B 246 B -
EV / Sales 2021 3,39x
EV / Sales 2022 3,97x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 43,94 $
Average target price 45,19 $
Spread / Average Target 2,84%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.20.05%247 760
JOHNSON & JOHNSON4.44%433 991
ROCHE HOLDING AG10.87%324 441
NOVO NORDISK A/S51.58%233 750
ELI LILLY AND COMPANY37.22%210 490
ABBVIE INC.-0.07%189 724